US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -18,067 | -13,181 | -7,327 |
| Depreciation Amortization | 3,127 | 236 | 46 |
| Accounts receivable | 27 | -8 | -72 |
| Accounts payable and accrued liabilities | 1,291 | 357 | -399 |
| Other Working Capital | 4,249 | 480 | -444 |
| Other Operating Activity | -357 | 4,286 | 2,430 |
| Operating Cash Flow | $-9,729 | $-7,830 | $-5,766 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -102 | -203 | -326 |
| Investing Cash Flow | $-102 | $-203 | $-326 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 10,000 | N/A | N/A |
| Common Stock Issued | 1,537 | 8,125 | 11,268 |
| Other Financing Activity | -1,240 | -224 | -200 |
| Financing Cash Flow | $10,298 | $7,900 | $11,068 |
| Beginning Cash Position | 5,025 | 5,158 | 182 |
| End Cash Position | 5,492 | 5,025 | 5,158 |
| Net Cash Flow | $467 | $-133 | $4,976 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,729 | -7,830 | -5,766 |
| Capital Expenditure | -102 | -203 | -326 |
| Free Cash Flow | -9,831 | -8,033 | -6,092 |